Premium
Private equity firm ChrysCapital Investment Advisors India Pvt. Ltd is set to walk away with a bountiful harvest from its almost six-year-old investment in drugmaker Eris Lifesciences Pvt. Ltd, which is floating its initial public offering (IPO) later this month.Eris Lifesciences has set a price band of Rs 600-603 per ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
